{TAIL ~ The invention} also comprises a pharmaceutical composition comprising a first antibody or an antigen binding fragment thereof, and a second antibody, or an antigen binding fragment thereof, wherein the first antibody is {HEAD ~ an antibody} of the invention, and the second antibody is an antibody that neutralizes hCMV infection 
{ TAIL ~ The invention } also comprises a pharmaceutical composition comprising a first antibody or an antigen binding fragment thereof , and a second antibody , or an antigen binding fragment thereof , wherein the first antibody is { HEAD ~ an antibody } of the invention , and the second antibody is an antibody that neutralizes hCMV infection
TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH